Navigation Links
New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting
Date:6/2/2008

se events included fatigue, hand/foot syndrome and skin rash.

The lead investigator for this study is Joan Schiller, MD, professor and chief of the hematology/oncology division at the University of Texas Southwestern and Andrea L. Simmons distinguished chair in cancer research, Dallas, TX. (abstract #8014).

Thyroid Cancer

A Phase 2 Study of Sorafenib in Metastatic Thyroid Carcinoma

Findings from this single-arm Phase 2 study showed that treatment with Nexavar resulted in meaningful anti-tumor activity in the majority of patients with encouraging overall clinical benefit (disease stabilization and partial responses) in patients with advanced thyroid cancer. In the study, Nexavar was well-tolerated; the most common treatment-related adverse events included fatigue, rash, diarrhea, palmer-plantar erythema, musculoskeletal pain and weight loss. Patients enrolled in this study had been diagnosed with metastatic, iodine-refractory, unresectable or locally-advanced thyroid cancer.

The lead investigator for this study is Marcia S. Brose, MD, PhD, assistant professor, director of cancer genetics laboratory, University of Pennsylvania Health System, Philadelphia, PA. (abstract #6026).

Gastrointestinal Stromal Tumors

Activity of Sorafenib in Patients with Imatinib and Sunitinib-Resistant Gastrointestinal Stromal Tumors (GIST): A Phase 2 Trial of the University of Chicago Phase 2 Consortium

Findings from this single-arm Phase 2 study suggest that Nexavar is active and well tolerated in patients with Gleevec or Gleevec and Sutent resistant GIST. The most common treatment-emergent adverse events included hand-foot syndrome, hypertension, rash and diarrhea.

The lead investigator for this study is Lauren Wiebe, MD, fellow, University of Chicago, Chicago, IL. (abstract #10502).

Gastric/GEJ

A Phase 2 Study: Combination of Sorafenib with Docetaxel and Cisplatin in the Treatment of Metastatic or Advanced Unres
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals, Inc.; OnyxPharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
2. Nexavar First FDA-Approved Drug Therapy for Liver Cancer
3. ZymoGenetics Reports Positive Phase 1 Results for IL-21 With Nexavar(R)
4. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
5. Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting
6. Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments
7. New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
8. Data To Be Presented at ASCO Supports Potential of Peregrines Cotara(R) for the Treatment of Brain Cancer
9. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
10. Two DOXIL(R) Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
11. Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... a group of national medical societies launched a multi-state ... Protection and Affordable Care Act, currently under consideration by ... final vote in the coming days. The groups ... a health care bill that is "bad medicine" for ... health care system needs reform - but the current ...
(Date:12/16/2009)... -- Medlytix, a national healthcare consulting firm, reported ... dollar milestone - the total amount of money ... assistance to more than a half-million patients nationwide ... charity care - in less than two years. ... enhanced their bottom lines and still were able ...
(Date:12/16/2009)... Calif., Dec. 16 Accuray Incorporated (Nasdaq: ... radiosurgery, announced today that its president and chief executive ... at the 28th Annual J.P. Morgan Healthcare Conference in ... a.m. PT/12:30 p.m. ET. ,, A live webcast ... investor relations page of the Company,s Web site at ...
Breaking Medicine Technology:Physician Groups Oppose Current Senate Health Care Reform Bill 2Healthcare Scoring System Allows Hospitals To Increase Charity Care 2Healthcare Scoring System Allows Hospitals To Increase Charity Care 3Healthcare Scoring System Allows Hospitals To Increase Charity Care 4Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference 2Prestige Care Inc Takes Over Operational Control of Former Mary Conrad Center 50801 1Prestige Care Inc Takes Over Operational Control of Former Mary Conrad Center 50801 2Brain Quickly Detects Happiness in Others 50796 1Brain Quickly Detects Happiness in Others 50796 2The Leukemia 26 Lymphoma Society and The International Waldenstroms Macroglobulinemia Foundation Partner to Develop Cell Lines to Advance Research 12902 1The Leukemia 26 Lymphoma Society and The International Waldenstroms Macroglobulinemia Foundation Partner to Develop Cell Lines to Advance Research 12902 2The Leukemia 26 Lymphoma Society and The International Waldenstroms Macroglobulinemia Foundation Partner to Develop Cell Lines to Advance Research 12902 3
(Date:12/17/2009)... Reportlinker.com announces that a new ... catalogue: ,, http://www.reportlinker.com/p0169956/Top-Ten-Worlds-Leading-Animal-Health-Companies.html ,, ... animal health industry executives with strategically significant ... the development and implementation of effective marketing ... include: ,, To establish a ...
(Date:12/17/2009)... following feature is by Devon Herrick, PhD, Senior Fellow ... People often assume they have little control over how ... sickness cannot be scheduled, doctors prescribe treatments and employers ... Americans. However, there are many overlooked ways to trim ... need. ,, Cut your prescription costs: ...
(Date:12/17/2009)... WASHINGTON, Dec. 17 The National Council ... meeting at the JW Marriott Houston, 5150 Westheimer, Houston, ... 2010, and ending at 11:00 a.m. on Thursday, January ... ,, NCD believes it is vital to hear ... what does not for people with disabilities. This meeting ...
(Date:12/17/2009)... MA Brandeis University selected Jay and Maureen Neitz, the ... use of gene therapy to treat vision disorders, as ... in Vision Sciences. , The award is funded by ... gift from Brandeis graduates Jay Pepose ,75 and Susan ... graduate research fellowships in vision science. , The Neitzes, ...
(Date:12/17/2009)... lung infections , , THURSDAY, Dec. 17 (HealthDay News) -- ... swine flu virus, and researchers say they,ve found a ... severity of the illness appears to be a molecule ... fight off germs and disease. Researchers who analyzed levels ... hospitals last summer found the highest levels in the ...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 2Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 3Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 4Health News:Six Ways to Slash Your Health Costs 2Health News:Six Ways to Slash Your Health Costs 3Health News:Six Ways to Slash Your Health Costs 4Health News:National Council on Disability to Hold Houston Meeting to Hear Issues Affecting People With Disabilities 2Health News:Vision researchers Jay and Maureen Neitz to receive first Pepose Award from Brandeis 2
... carried out simultaneous raids on some government hospital doctors ... on Monday.// ,The raids were conducted in Chennai, ... of the investigating agency said., ,The houses of ... Uma Goel of Sucheta Kriplani Hospital here were searched, ...
... live mutated viruses can cure tumors in animals and humans.,Scientists ... a patient with an aggressive //form of brain cancer after ... ,A mutation of the herpes virus was injected into ... live in 1997. But, eight years later he is still ...
... Apollo Hospitals Group plans to invest Rs 350 crore to ... planned new addition of 1800 beds, Apollo Group's total capacity ... ,"There is a plan for adding 800 beds through ... Apollo Hospitals Group Director Finance, Suneeta Reddy, said here on ...
... lead to a multitude of complications if left untreated. ... possibility of using tea as a form of treatment ... found to prevent the incidence of cataracts, a significant ... , ,Researchers developed special rats with diabetes. This ...
... cases in India is probably much higher than official data ... ,India, which has 5.1 million people with AIDS or ... in 2005 that new infections had sharply fallen to 28,000 ... aid groups have expressed skepticism about those figures. Peter ...
... exercise capacity and functional ability in patients with pulmonary ... the blood vessels that enter the lungs, a new ... the findings, which appear in The New England Journal ... patients who were randomly selected to receive Viagra, at ...
Other Medicine News:
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: